Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Assessment at 24 Months Post-Vaccination of the Non-Inferiority of the Concurrent Administration of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine and Measles Vaccine to Measles Vaccine Given Alone

NCT00412516 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT00412516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00412516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Assessment at 24 Months Post-Vaccination of the Non-Inferiority of the Concurrent Administration of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine and Measles Vaccine to Measles Vaccine Given Alone
Lead sponsor
PATH
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2006
Completion date
March 31, 2010
Enrollment
519 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

encephalitis, japanese b